Axsome Therapeutics, Inc. (AXSM)
146.22
-1.95
(-1.32%)
USD |
NASDAQ |
Dec 15, 16:00
146.22
0.00 (0.00%)
After-Hours: 20:00
Axsome Therapeutics Research and Development Expense (Annual): 186.54M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 303.25M |
| Fortress Biotech, Inc. | 56.88M |
| TG Therapeutics, Inc. | 94.29M |
| Karyopharm Therapeutics, Inc. | 142.89M |
| Viking Therapeutics, Inc. | 101.64M |